Efficacy and tolerability of telmisartan plus amlodipine in added-risk hypertensive patients
2011
AbstractObjectives:Added-risk hypertensive patients with co-morbidities such as diabetes and metabolic syndrome often require two or more antihypertensives to achieve blood pressure (BP) targets. The aim of this sub-analysis was to determine the efficacy and safety of telmisartan 40 or 80 mg plus amlodipine 5 or 10 mg in patients with hypertension, stratified according to certain criteria such as type 2 diabetes mellitus and metabolic syndrome.Methods:Patients were treated for 8 weeks with telmisartan 20–80 mg plus amlodipine 2.5–10 mg. This post-hoc analysis included patients treated with higher doses, and stratified according to a number of sub-populations (age, race, diabetes, obesity, metabolic syndrome, elevated baseline systolic BP (SBP), renal impairment).Results:Eight weeks’ treatment with telmisartan plus amlodipine combinations provided consistent reductions in mean SBP/diastolic BP (DBP) across the different sub-populations, similar to the overall population. SBP/DBP reductions ranged from −13....
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
28
References
11
Citations
NaN
KQI